The protection industry has made progress in communicating with consumers but more needs to be done and now maybe the time for product innovation, Swiss Re has said.
Competition can be a good thing for the NHS but private companies should not be allowed to cherry pick certain patients, according to the NHS Future Forum.
Governments across Europe are getting on board to help people stop smoking. Ross Campbell discusses nicotine replacement therapy's underwriting implications
Jobcentre Plus staff have revealed ‘serious reservations' about a nationwide roll-out the reassessment of incapacity benefit claimants for Employment and Support Allowance (ESA).
It all began 25 years ago with the launch of the UK's first ever critical illness products by Abbey Life and Allied Dunbar. Scottish Provident's Jennifer Gilchrist looks back on a seminal moment in the history of protection...
NEST (the National Employment Savings Trust) could open the door to expansion of the group life market, according to new research.
Insurers have agreed to continue not using genetic test results for the vast majority of insurance policies until 2017.
Simplyhealth believes the government has failed to make its case for NHS reforms and that taking stock of public and health professionals' reaction will improve the amendments.
Disabled people receiving the Personal Independence Payment (PIP) will be subject to regular reassessments and the majority of cases will be fixed-term payments.
The government is aware a considerable expansion in the group income protection market (GIP) is one option for its review of the welfare and sickness absence system.